Heat Biologics Inc. (HTBX)

1.73 -0.05 (-2.809%)

IEX Real-Time Price

October 19, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 1.78

Price Open 1.79

Volume: 179,844

Avg Volume: 150,666

Market Cap: 40.01M

P/E Ratio -1.09

52 Wk Range 1.09-6.7



HTBX Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-09-28
21.1M
864,054
4.50
4.10%

2018-09-14
21.1M
853,493
3.83
4.05%

2018-08-31
21.1M
1.01M
4.74
4.77%

2018-08-15
21.1M
1.16M
5.47
5.52%




HTBX Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-08-14
Q2 2018
N/A
-0.18 (3)
-0.23
-0.05

2018-05-15
Q1 2018
N/A
0.00 (0)
-0.75
0.00

2018-03-30
Q4 2017
N/A
0.00 (0)
0.00
0.00

2017-11-13
Q3 2017
N/A
-0.10 (2)
-0.06
0.04

News

Premarket analyst action - healthcare (2018-07-09 08:18 SeekingAlpha)

CVS Health (NYSE: CVS ) assumed with Buy rating and $81 (22% upside) price target at Citigroup. Shares up a fraction premarket. More news on: CVS Health Corporation, Heat Biologics, Inc., MeiraGTx Holdings plc, Healthcare stocks news, Stocks on the move, , Read more …

 


Statistics

Shares Outstanding: 23.13M

Top 15 Institution Percent: 4.40

Price To Sales: 67.09

Price To Book: 1.50

Revenue: 470823

Gross Profit: N/A

Cash: 4.29M

Debt: N/A

Return On Assets: -47.72

Return On Equity: -69.18

Profit Margin: N/A

Price History

Beta: 1.15

50-day Moving Avg: 1.91

200-day Moving Avg: 2.19

YTD Change: -55.64

5-day Change: 5.49

1-month Change: -8.47

3-month Change: -24.12

6-month Change: 40.21

1-year Change: -72.50

Revenue Per Share: 0.00

Revenue Per Employee: 24780.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Heat Biologics Inc.

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.heatbio.com

Heat Biologics Inc is a US-based immuno-oncology company. It is engaged in developing therapies which activate a patient's immune system against cancer utilizing an engineered form of gp96.